Translation and Adaptation of Learning Organisation Survey for French Speaking Countries
NCT ID: NCT04130568
Last Updated: 2019-10-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
110 participants
OBSERVATIONAL
2019-08-01
2019-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aim : described the translation of Garvin's et al. Learning Organization Survey into French to evaluate french speaking health organizations.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cancer and Literacy in Health
NCT05008497
Prevention of NCDs Through Screening and Educating Individuals on Health-risk Behaviours in the Community
NCT05790395
The Use of a Community-based Organization to Change Lifestyle Characteristics Related to Non Communicable Diseases
NCT01174381
Health Related Quality of Life in Lung Transplantation in Strasbourg
NCT04667806
Effectiveness of a Educational Intervention to Improve the Resolution Capacity of Primary Health Care Teams.
NCT00140283
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Translation and Back-translation The first step in the process was the translation of the English LO survey by Garvin et al. (En1) based on the modified Brislin reverse translation technique.
During the translation, it was necessary to adapt some terms to maintain the same meaning as the original.
During the back-translation of the survey, no items were found that needed alteration.
The translated and back translated versions of the survey we ll be presented to a commission of 10 multidisciplinary staff from the INO. As a final part of this process, the content validity of the questions will be verified for each item of the survey.
After the necessary adjustments comparing the original survey (En1) with the back translated version (En2) and the french draft (Fr1); the french final version (FFr) of the survey will be generated and assessed in terms of conceptual equivalence, clarity and language and forwarded to the general coordinator of the project who will indicate adjustments.
Adaptation The FFr of the survey will be presented to a commission of experts in a workshop for cultural adequacy. On the day of the meeting, All multidisciplinary groups together will finish discussing and validating the pre-final french survey by mutual agreement (PFV).
Pilot test The objective of the pilot study will be to establish whether the questionnaire can be satisfactorily understood and completed by people from the target population, composed of doctors, nurses, administrators, professors. The possibility of adjustments will be considered in case the participants had difficulty understanding or responding to some item of the instrument.
Data collection The survey will be conducted anonymously and voluntarily; It will be distributed to a random sample of INO staff members, from doctors, administrators, residents, professors, nurses, technicians, secretaries. And then collected by members of the research team during August 2019.
Descriptive variables of the population were added such as: age, sex, status, years of experience, years worked in the INO and service they serve.
Analysis
The data collected will be analysed using both Excel® and IBM SPSS Statistics V22.0.
Continuous variables will be presented with mean and standard deviations(SD). Categorical variables will presented with percentage.
Normality test of the variables will be calculated using Kolmogorov-Smirnov test of normality. Cronbach's alpha coefficients will be used to assess reliability and internal consistency for each dimension, each block and the entire survey.
ANOVA test will be used to compare descriptive statistics of different groups of profession and the different Blocks and Dimensions of the survey.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
INO survey
Garvin's Learning organisation tool
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* (2) present on the days of the survey from the 1st to 31st August 2019 (
* 3\) willing to answer anonymously to this survey. Workers who were absent or on vacation were excluded as well as support staff (security and cleaning due to their frequent rotation).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut National d'Oncologie Sidi Mohammed Ben Abdellah
UNKNOWN
Moroccan Society of Surgery
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amine Souadka
professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institut of Oncology, Surgical oncology department
Rabat, , Morocco
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Garvin DA. Building a learning organization. Harv Bus Rev. 1993 Jul-Aug;71(4):78-91.
Akhnif E, Macq J, Idrissi Fakhreddine MO, Meessen B. Scoping literature review on the Learning Organisation concept as applied to the health system. Health Res Policy Syst. 2017 Mar 1;15(1):16. doi: 10.1186/s12961-017-0176-x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INO_Survey
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.